|
Volumn 59, Issue 11, 2002, Pages 1077-1082
|
Implementation of a therapeutic-interchange clinic for HMG-CoA reductase inhibitors
a a a a a a a a a a |
Author keywords
Ambulatory care; Antilipemic agents; Atorvastatin; Cerivastatin; Costs; Hypercholesterolemia; Pravastatin; Simva statin; Substitution
|
Indexed keywords
ATORVASTATIN;
CERIVASTATIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
SIMVASTATIN;
PYRIDINE DERIVATIVE;
ADULT;
AGED;
ALGORITHM;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
COST BENEFIT ANALYSIS;
DISEASE CONTROL;
DYSLIPIDEMIA;
FEMALE;
HEALTH CARE ORGANIZATION;
HEALTH CARE POLICY;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
OUTCOMES RESEARCH;
PATIENT EDUCATION;
PATIENT MONITORING;
PRIORITY JOURNAL;
TREATMENT PLANNING;
ECONOMICS;
METHODOLOGY;
MIDDLE AGED;
MONITORING;
ORGANIZATION AND MANAGEMENT;
OUTPATIENT DEPARTMENT;
PUBLIC HOSPITAL;
AGED;
AMBULATORY CARE FACILITIES;
FEMALE;
HOSPITALS, MILITARY;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MALE;
MIDDLE AGED;
MONITORING, PHYSIOLOGIC;
PATIENT EDUCATION;
PYRIDINES;
SIMVASTATIN;
|
EID: 0036591446
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/59.11.1077 Document Type: Article |
Times cited : (23)
|
References (14)
|